Related Experiment Video
Updated: Sep 14, 2026
Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy
Published on: April 29, 2014
Antiproliferative effects of four different cytokines on renal carcinoma cell lines
1Department of Urology, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany.
Abstract:
The effect of alpha-Interferon (alpha-IFN), gamma-interferon (gamma-IFN), tumor necrosis factor alpha (TNF-alpha) and interleukin-2 (Il-2) on growth of two renal cancer cell lines (DNT-11, HTB-44) was studied. Cell proliferation was measured by a tetrazolium based microculture assay (MTT) after incubation of tumor cells with different concentrations of these 4 cytokines over 72 hours. TNF-alpha showed no antiproliferative effect when cell line DNT-11 was tested, even at high concentrations of 1.000 ng/ml. Proliferation of the other cell line (HTB-44) was only slightly reduced (15%) at 100 ng/ml; a tenfold increase of TNF concentration could not improve these results. The antiproliferative effect of alpha-IFN was in the range of 22-26%. When gamma-IFN was used, both cell lines showed reduction of proliferation between 26% and 37%, respectively. Kinetic studies revealed that prolongation of incubation time for more than 72 hours was not able to improve these results. Il-2 did not influence cell proliferation of either cell line tested, even at high concentrations, as expected.
Insights
Cytokines like gamma-interferon (gamma-IFN) and alpha-interferon (alpha-IFN) showed antiproliferative effects on renal cancer cell lines. Tumor necrosis factor alpha (TNF-alpha) and interleukin-2 (IL-2) demonstrated minimal to no impact on cancer cell growth.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Cytokines are crucial signaling molecules in immune responses.
- Understanding cytokine effects on cancer cells is vital for targeted therapies.
- Renal cell carcinoma (RCC) remains a significant health concern with limited treatment options.
Purpose of the Study:
- To investigate the antiproliferative effects of four key cytokines on renal cancer cell lines.
- To compare the efficacy of alpha-interferon (alpha-IFN), gamma-interferon (gamma-IFN), tumor necrosis factor alpha (TNF-alpha), and interleukin-2 (IL-2).
Main Methods:
- Two human renal cancer cell lines (DNT-11 and HTB-44) were utilized.
- Cells were incubated with varying concentrations of alpha-IFN, gamma-IFN, TNF-alpha, and IL-2 for 72 hours.
- Cell proliferation was quantified using a tetrazolium-based microculture assay (MTT).
Main Results:
- Gamma-interferon (gamma-IFN) reduced proliferation by 26-37%, while alpha-interferon (alpha-IFN) showed a 22-26% reduction.
- Tumor necrosis factor alpha (TNF-alpha) exhibited minimal antiproliferative effects (up to 15%) on one cell line.
- Interleukin-2 (IL-2) did not significantly affect the proliferation of either renal cancer cell line.
- Prolonging incubation beyond 72 hours did not enhance the observed antiproliferative effects.
Conclusions:
- Gamma-interferon and alpha-interferon show potential as therapeutic agents against renal cancer cell lines.
- TNF-alpha and IL-2 appear to have limited direct antiproliferative activity on these specific renal cancer models.
- Further research into cytokine combinations and mechanisms may yield more effective cancer treatments.
